Loading...
Images of Bo Cumbo
(0 from 0 )News
Bo Cumbo Profile | CipherBio
www.cipherbio.com
Find out what research areas Bo Cumbo is interested in, their current and past organizations and any investments they've made here! Home. PRO Data . PRO Dashboards. Neuro Insights $27B+ Gene Therapy Insights $19B+ Autoimmune Insights $24B+ COVID-19 Insights $7.5B+ Metabolic Disorders $15B+ Clinical Dashboards . Clinical Dashboards. Neuro Insights $27B+ Gene …
AavantiBio Launches with $107 Million Bain Capital
www.baincapital.com
· Ingram continued: “Bo Cumbo has built a first-in-class rare disease commercial organization and has made tremendous contributions to Sarepta. We look forward to continuing to work with Bo as he builds a strong AavantiBio team and advances therapies to treat FA and other rare diseases.” Prior to joining Sarepta in 2013, Mr. Cumbo served as Vice President of Sales …
Auburn COSAM alum dedicated to curing diseases with new ...
ocm.auburn.edu
· Auburn alum Bo Cumbo is dedicated to saving the world – by defeating one rare disease at a time. The laboratory technology graduate is busy building his newest gene therapy venture, AavantiBio, as he puts more than a quarter century of experience to work fighting rare or specialty diseases.
Sarepta helps bankroll new gene therapy startup AavantiBio
pharmaphorum.com
· Phil Taylor October 22, Sarepta chief commercial officer Bo Cumbo has left to head up gene therapy venture – AavantiBio – with $107 million in backing from his former employer and three...
sorted by relevance / date